BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Short Interest Update

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) was the target of a significant increase in short interest in December. As of December 31st, there was short interest totalling 3,200 shares, an increase of 10.3% from the December 15th total of 2,900 shares. Based on an average trading volume of 154,200 shares, the short-interest ratio is presently 0.0 days.

BriaCell Therapeutics Price Performance

BCTXW remained flat at $0.15 on Friday. The company had a trading volume of 210 shares, compared to its average volume of 111,150. The business has a fifty day moving average price of $0.31 and a 200-day moving average price of $0.27. BriaCell Therapeutics has a 1 year low of $0.11 and a 1 year high of $2.30.

BriaCell Therapeutics Company Profile

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.